Pharmacokinetics, Safety and Tolerance of Voriconazole in Renally??Impaired Subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics, Safety and Tolerance of Voriconazole in Renally??Impaired Subjects

Published:2008 Issue:7 Volume:28 Page:409-420
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clinical Drug Investigation

Author:

Abel Samantha,Allan Richard,Gandelman Kuan,Tomaszewski Konrad,Webb David J,Wood Nolan D

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Reference18 articles.

1. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus

2. In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem

3. In Vitro Activity of the New Triazole Voriconazole (UK-109,496) against Opportunistic Filamentous and Dimorphic Fungi and Common and Emerging Yeast Pathogens

4. Voriconazole: A second-generation triazole

5. Current and Emerging Azole Antifungal Agents

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Replacement Therapy as a New Indicator of Voriconazole Clearance in a Population Pharmacokinetic Analysis of Critically Ill Patients;Pharmaceuticals;2024-05-22

2. Your Outpatient has Coronavirus Disease 2019: What Are the Treatment Options in the Current Severe Acute Respiratory Syndrome Coronavirus 2 Variant Climate?;Clinical Infectious Diseases;2023-03-31

3. Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic Review;American Journal of Therapeutics;2022-07-22

4. Voriconazole injection may induce delayed methotrexate excretion: a case report and experimental study;Journal of Pharmaceutical Health Care and Sciences;2022-03-26

5. Primary renal aspergillosis in a newborn: a case report and review of the literature on children;The Turkish Journal of Pediatrics;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3